New Biopharmaceutical Company Sitryx Launches with $30 Million Fundraising to Develop Disease Modifying Therapeutics in Immunometabolism October 8, 2018
Merck KGaA, Darmstadt, Germany Selects ArcherDX for Strategic Global Companion Diagnostic Assay Development Collaboration October 3, 2018
Millendo Therapeutics Appoints Acceleron CEO Habib Dable to its Board of Directors September 25, 2018
Verastem Oncology Signs Exclusive License Agreement for the Development and Commercialization of COPIKTRA™ (duvelisib) in China September 25, 2018
